NextCell Sverige AB
559496-7282ActiveDeveloping revolutionary stem cell therapies for autoimmune diseases.
Oversigt
- 0
- Medarbejdere
- Ukendt
- Omsætning
- 2024
- Grundlagt
Nøglebeslutningstagere
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
+8 flere kontakter i Funnelfeedr
Beskrivelse
NextCell Pharma is a Swedish biotechnology company focused on revolutionizing treatments for severe and incurable diseases using stem cell therapies. The company operates three main business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). Thei...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559496728201
Beslutningstagere
12 kontakter i FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
Sofia Sisay
Head of Clinical Trials
Hans-Peter Ekre
Chairman of the Board
Eva Sjökvist Saers
Board Member
Camilla Myhre Sandberg
Board member
Sofie Falk Jansson
CEO of Cellaviva
Andre kontakter
Per-Ola Carlsson
Advisor
Eric Strati
Advisor
Angela Vollstedt
Advisor
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrCellaviva AB
5–9 medarbejdereScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 medarbejdereSpecialist quality control analytics provider for cell and gene therapies.
CELLINK Bioprinting AB
20–49 medarbejdereLeading provider of advanced 3D bioprinting systems and biomaterials.
Fluicell AB
10–19 medarbejdereDeveloping precision-engineered tissues using single-cell bioprinting technology.
Xintela AB
10–19 medarbejdereDeveloping stem cell and targeted cancer therapies for unmet needs.
Udforsk mere
Spørgsmål om NextCell Sverige AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo